Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

7 Tools to Identify Depression

Nancy Sharby, PT, DPT, MS  |  Issue: August 2014  |  August 1, 2014

Most notable for professionals working with patients with arthritic conditions is the fact that higher levels of depression are associated with increased levels of pain, fatigue, physical distress, levels of disability, worse outcomes following knee replacement, poorer overall health and greater use of healthcare resources.8,9,15 Generally, the more severe the depression, the greater the number and intensity of physical symptoms, which are accompanied by significant restriction of life activities.10 Typically, arthritic patients with depression will present to their care providers with physical symptoms that are seen in both arthritis and depression. As noted above, each of these conditions increases both the symptoms and disease burden of the co-occuring conditions, including joint pain, loss of energy, poor sleep, poor appetite and fatigue. Healthcare providers who treat patients with arthritis must be aware of the impact of this comorbidity and consider depression screening for all patients, but most especially for those patients whose arthritis symptoms increase in severity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Table 2: U.S. Preventive Services Screening Task Force Recommendations22

click for large version
Table 2: U.S. Preventive Services Screening Task Force Recommendations22

Effectiveness of Screening Tools

The gold standard for diagnosing depression is a structured, or semi-structured, interview by a mental health professional. However, this is neither feasible nor necessary. Multiple screening tools are available that can be easily administered in medical settings. Efficacious tools need to have both good sensitivity and specificity. Sensitivity will rule in, or yield, an accurate number of patients with the condition being screened. Test specificity, on the other hand, will rule out or exclude patients who do not have the target condition without identifying too many false negatives. A concern with test specificity is that too many affected individuals will be missed. Test sensitivity and specificity that are close to 1 are desirable, and .8 is considered good. A test with a sensitivity of .8 will capture 80% of patients who have the disorder being screened for. A specificity of .8 will rule out 80% of patients without the target condition.21

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Prevalence rates on these tools will be affected by the threshold for a positive screen that can be raised or lowered to suit the preferences of the examiner. Patients who screen positive for depression will need to be followed up with a structured or semi-structured interview to determine its actual presence.

The U.S. Preventive Services Task Force (USPSTF) has developed recommendations for depression screening in medical settings.22 They found there is ample evidence that depression screening improves the identification of depression in primary care settings and improves outcomes for patients. A summary of their recommendations is found in Table 2. All positive screens should be referred for a follow-up diagnostic interview. The best outcomes have resulted when the depression results are communicated with patients and other relevant professionals to facilitate effective intervention and follow-up. Screenings in isolation from intervention and follow-up do not improve outcomes.

Page: 1 2 3 4 5 6 7 8 9 10 | Single Page
Share: 

Filed under:Career DevelopmentConditionsEducation & TrainingOsteoarthritis and Bone DisordersProfessional TopicsResearch RheumRheumatoid ArthritisVasculitis Tagged with:Association of Rheumatology Professionals (ARP)DepressionOsteoarthritispatient carepsychological disorderResearchRheumatoid arthritisscreeningsymptom

Related Articles

    Depression in Rheumatoid Arthritis

    November 1, 2012

    Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

    Study Examines How Depression Subtypes May Stem from Osteoarthritis

    October 18, 2019

    People with or at risk for sympto­matic knee osteoarthritis (OA) may be assigned to four depression subtypes with distinct clusters of depressive symptoms that may affect pain and disability over time, according to a new study in Arthritis Care & Research.1 Four depression subtypes were identified in the study using the Center for Epidemiologic Studies…

    Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

    April 2, 2014

    Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences